Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept in Psoriasis and Psoriatic Arthritis: single-center open-label study
2004-004691-37Phase 4Completed
- Sponsor
- St. Vincent's University Hospital
- Start
- Jan 2005
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of etanercept in psoriasis and psoriatic arthritis (PsA), sponsored by St. Vincent's University Hospital. Primary endpoint: Primary efficacy signal at week 12. Started Jan 2005; status: completed.
02
Drugs
etanercept
03
Conditions
psoriasispsoriatic arthritis (PsA)
Beyond the preview
Go deeper on 2004-004691-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004691-37.